Physician profile
Traiana D Pacurar
NPI 1811986003
$1,399.94
in general payments reported to CMS, 2019-2025
16 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Adolescent Medicine (Internal Medicine) provider received nationally (typical 2025 total: $165).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.12 · 2020: $140 · 2021: $245 · 2022: $276 · 2023: $204 · 2024: $318 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $420.50 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.57 | 2023-2025 | Jardiance |
| Abbvie INC. | $147.01 | 2021-2025 | |
| Lilly USA, LLC | $139.70 | 2020-2025 | Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $114.08 | 2021-2022 | |
| Exact Sciences Corporation | $80.20 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $68.92 | 2022-2024 | |
| Pfizer INC. | $68.01 | 2023-2024 | |
| Astrazeneca Pharmaceuticals Lp | $63.74 | 2024-2025 | Farxiga, Airsupra |
| Amgen INC. | $31.71 | 2020-2024 | Repatha, Otezla |
| Phathom Pharmaceuticals, INC. | $30.26 | 2024-2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $21.23 | 2024 | Rexulti |
| Eyevance Pharmaceuticals LLC | $18.12 | 2021 | |
| Hikma Pharmaceuticals USA | $18.12 | 2021 | |
| Merck Sharp & Dohme LLC | $12.86 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traiana Pacurar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.